Recent Advances in Drugs and Prodrugs Design in the Field of Infectious Diseases
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Physical Pharmacy and Formulation".
Deadline for manuscript submissions: closed (30 June 2024) | Viewed by 3598
Special Issue Editors
Interests: antimalarial and anticancer agents
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Infectious diseases are among the top leading causes of death worldwide. The emergence of resistant microorganisms and new viruses poses a great threat to the efficacy of currently available antimicrobial agents. Therefore, novel antimicrobial strategies are urgently needed. One of the mostly explored and extensively employed strategies in drug discovery is the design of prodrugs, which can positively influence both the pharmacokinetics and pharmacodynamics of the parent drug.
We invite researchers to submit their original research articles and/or reviews that cover areas including (but not limited to) the following:
- Computational chemistry in the field of antimicrobial agents;
- Discovery of new antimicrobial agents (small molecules/peptides/macromolecules);
- Identification of new antimicrobial drug targets;
- Prodrugs in the therapy of infectious diseases;
- Natural products in antimicrobial drug discovery.
We look forward to receiving your contributions.
Prof. Dr. Zrinka Rajić
Prof. Dr. Ivana Perković
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial agent
- antimicrobial resistance
- synthesis
- prodrugs
- natural products
- drug target
- computational chemistry in drug discovery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
